hVIVO plc (LON:HVO) Insider Sells £6,136,161.04 in Stock

hVIVO plc (LON:HVO) insider Cathal Friel sold 21,159,176 shares of the business’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of GBX 29 ($0.38), for a total transaction of £6,136,161.04 ($7,936,059.29).

hVIVO Stock Performance

Shares of HVO opened at GBX 29.75 ($0.38) on Friday. The company’s 50 day moving average price is GBX 27.51 and its 200 day moving average price is GBX 27.76. hVIVO plc has a 52 week low of GBX 16.25 ($0.21) and a 52 week high of GBX 32 ($0.41). The company has a market capitalization of £202.41 million, a PE ratio of 1,500.00 and a beta of 1.02. The company has a debt-to-equity ratio of 36.50, a quick ratio of 1.16 and a current ratio of 1.48.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.